Ishares Biotechnology Etf Price on October 31, 2024
| IBB Etf | USD 136.10 1.26 0.93% |
Below is the normalized historical share price chart for iShares Biotechnology ETF extending back to February 09, 2001. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of IShares Biotechnology stands at 136.10, as last reported on the 22nd of November, with the highest price reaching 136.61 and the lowest price hitting 133.62 during the day.
If you're considering investing in IShares Etf, it is important to understand the factors that can impact its price. iShares Biotechnology ETF holds Efficiency (Sharpe) Ratio of -0.11, which attests that the entity had a -0.11% return per unit of risk over the last 3 months. iShares Biotechnology ETF exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out IShares Biotechnology's Standard Deviation of 1.12, risk adjusted performance of (0.08), and Market Risk Adjusted Performance of (0.13) to validate the risk estimate we provide.
IShares Etf price history is provided at the adjusted basis, taking into account all of the recent filings.
3 y Volatility 18.91 | 200 Day MA 139.4917 | 1 y Volatility 18.79 | 50 Day MA 143.818 | Inception Date 2001-02-05 |
IShares |
Sharpe Ratio = -0.1085
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IBB |
Estimated Market Risk
| 1.12 actual daily | 9 91% of assets are more volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average IShares Biotechnology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of IShares Biotechnology by adding IShares Biotechnology to a well-diversified portfolio.
Average Mkt Cap Mil 21.6 K |
IShares Biotechnology Main Headline on 31st of October 2024
O ROURKE COMPANY Inc Grows Stock Holdings in iShares Biotech... by thelincolnianonline.com
O ROURKE COMPANY Inc boosted its position in iShares Biotechnology ETF by 3.5 percent during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission . The institutional investor owned 6,859 shares of the financial services providers stock after buying an additional 234 shares during
IShares Biotechnology Valuation on October 31, 2024
It is possible to determine the worth of IShares Biotechnology on a given historical date. On October 31, 2024 IShares was worth 141.24 at the beginning of the trading date compared to the closed value of 140.29. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of IShares Biotechnology etf. Still, in general, we apply an absolute valuation method to find IShares Biotechnology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of IShares Biotechnology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against IShares Biotechnology's related companies.
| Open | High | Low | Close | Volume | |
| 141.95 | 143.50 | 141.95 | 142.41 | 1,020,881 | |
10/31/2024 | 141.24 | 141.54 | 140.05 | 140.29 | 1,644,910 |
| 141.29 | 142.82 | 140.89 | 142.78 | 1,388,314 |
| Backtest IShares Biotechnology | | | IShares Biotechnology History | | | IShares Biotechnology Valuation | Previous | Next |
IShares Biotechnology Trading Date Momentum on October 31, 2024
| On November 01 2024 iShares Biotechnology ETF was traded for 142.78 at the closing time. Highest IShares Biotechnology's price during the trading hours was 142.82 and the lowest price during the day was 140.89 . The net volume was 1.4 M. The overall trading history on the 1st of November contributed to the next trading period price jump. The trading delta at closing time to the next next day price was 1.77% . The trading date delta to current price is 6.46% . |
iShares Biotechnology ETF Fundamentals Correlations and Trends
By evaluating IShares Biotechnology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among IShares Biotechnology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. IShares financial account trend analysis is a perfect complement when working with valuation or volatility modules.About IShares Biotechnology Etf history
IShares Biotechnology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for IShares is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in iShares Biotechnology ETF will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing IShares Biotechnology stock prices may prove useful in developing a viable investing in IShares Biotechnology
The fund generally will invest at least 80 percent of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20 percent of its assets in certain futures, options and swap contracts, cash and cash equivalents. Nasdaq Biotechnology is traded on NASDAQ Exchange in the United States.
IShares Biotechnology Etf Technical Analysis
IShares Biotechnology technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
Price Boundaries
IShares Biotechnology Period Price Range
Low | November 22, 2024
| High |
0.00 | 0.00 |
iShares Biotechnology ETF cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
IShares Biotechnology November 22, 2024 Market Strength
Market strength indicators help investors to evaluate how IShares Biotechnology etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading IShares Biotechnology shares will generate the highest return on investment. By undertsting and applying IShares Biotechnology etf market strength indicators, traders can identify iShares Biotechnology ETF entry and exit signals to maximize returns
IShares Biotechnology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for IShares Biotechnology's price direction in advance. Along with the technical and fundamental analysis of IShares Etf historical price patterns, it is also worthwhile for investors to track various predictive indicators of IShares to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.28) | |||
| Treynor Ratio | (0.14) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Biotechnology ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
The market value of iShares Biotechnology ETF is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is IShares Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Biotechnology's market value can be influenced by many factors that don't directly affect IShares Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.